TW
Therapeutic Areas
Sanuwave Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UltraMIST® Therapy System | Chronic, Non-Healing Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers) | Commercial |
Leadership Team at Sanuwave
MF
Morgan Frank
Chief Executive Officer & Chairman of the Board
PS
Peter Sorensen
Chief Financial Officer
DL
Dustin Libby
Executive Vice President of Commercial Operations
JT
Jim Tyler
Director
IM
Ian Miller
Director
JB
Jeffrey Blizard
Director
GB
Greg Bazar
Director